colchicine has been researched along with Cardiovascular Stroke in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.94) | 18.7374 |
1990's | 3 (2.91) | 18.2507 |
2000's | 4 (3.88) | 29.6817 |
2010's | 21 (20.39) | 24.3611 |
2020's | 73 (70.87) | 2.80 |
Authors | Studies |
---|---|
Aguilhon, S; Akodad, M; Cardon, F; Cristol, JP; Delbaere, Q; Delseny, D; Dupasquier, V; Dupuy, AM; Gervasoni, R; Huet, F; Jammoul, N; Kahlouche, S; Leclercq, F; Macia, JC; Mariano-Goulart, D; Nagot, N; Roubille, F; Soltani, S | 1 |
Büyükulaş, C; Karahan, E; Polat, YO; Şen, S; Üresin, AY | 1 |
Budhathoki, P; Elgendy, I; Khadka, M; Mir, WAY; Patel, NK; Patel, T; Pokharel, S; Sedhai, Y; Shrestha, DB; Yadav, S | 1 |
He, QZ; Little, PJ; Qin, CH; Weng, JP; Xu, SW; Zhang, FS | 1 |
Chen, Y; Fu, Y; Jiang, Y; Li, M; Liu, Y; Luo, W; Wu, Y; Xia, H; Xu, C; Zhang, H | 1 |
Attar, A; Kazemi, A; Ramezani, A; Razavi, E | 1 |
Barhdadi, A; Dubé, MP; Hennessy, T; Hillis, GS; Rhainds, D; Schultz, CJ; Sun, M; Tardif, JC | 1 |
Shen, S; Shu, Y; Tang, X; Wan, H; Xiao, R; Zeng, L | 1 |
Aghakouchakzadeh, M; Alidoosti, M; Etesamifard, N; Gheymati, A; Hosseini, SH; Jalali, A; Jenab, Y; Kakavand, H; Sadeghian, M; Tajdini, M; Talasaz, AH; Van Tassell, BW | 1 |
Bao, YL; Du, C; Gu, LF; Wang, LS; Wang, YX | 1 |
Jiang, W; Song, X; Tian, J; Yong, J; Zhang, H; Zhao, X | 1 |
Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Prins, FJ; Ronner, E; Schut, A; Thompson, PL; Tijssen, JGP | 1 |
Prayitnaningsih, S; Rohman, MS; Suryono, S; Widjajanto, E; Wihastuti, TA | 1 |
Chen, W; Fan, FD; Han, XK; Jiang, CY; Jiang, XY; Pan, J; Pan, T; Wang, CS; Wang, DJ; Wang, K; Zhang, H; Zhang, HT; Zhang, L; Zhou, Q | 1 |
Alam, M; Jhamnani, S; Jhaveri, A; Kontopantelis, E; Mamas, MA; Savinova, OV; Siddiqui, E | 1 |
De Sarro, G; Gallelli, L; Lochner, P; Siniscalchi, A | 1 |
Andel, PM; Atar, D; Aukrust, P; Gleditsch, J; Gude, E; Haugeberg, G; Høie, S; Salte, T; Steine, K | 1 |
Cai, X; Hu, S; Ji, L; Li, Z; Lin, C; Lv, F; Yang, W; Zhu, X | 1 |
Fuster, V; Nelson, K; Ridker, PM | 1 |
Oktaviono, YH; Prayitnaningsih, S; Rohman, MS; Suryono, S; Widjajanto, E; Wihastuti, TA | 1 |
Bajpai, R; Clarson, LE; Forrester, H; Mallen, CD; Muller, S; Padmanabhan, N; Partington, RJ; Roddy, E; Whittle, R | 1 |
Entezari-Maleki, T; Khezerlouy-Aghdam, N; Khiali, S; Namdar, H; Rezagholizadeh, A; Salehi, R; Sarbakhsh, P; Taban-Sadeghi, M | 1 |
He, X; Huang, S; Long, Q; Qi, Z; Qian, B; Shi, H; Wang, X; Ye, X; Zhang, Y; Zhao, Q; Zhong, Y | 1 |
Bax, WA; Budgeon, CA; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Schut, A; Thompson, PL; Tijssen, JGP | 1 |
Newby, LK | 1 |
Angoulvant, D; Berry, C; Bertrand, OF; Blondeau, L; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lavoie, MA; López-Sendón, J; Maggioni, AP; Orfanos, A; Ostadal, P; Pinto, FJ; Provencher, M; Rhainds, D; Roubille, F; Tardif, JC; Waters, DD | 1 |
Lim, GB | 1 |
Kashou, AH; May, AM; Noseworthy, PA | 1 |
Blumenthal, RS; Gulati, M; Mahtta, D; Mehta, A; Sperling, LS; Virani, SS | 1 |
Chen, Y; Ding, J; Jin, X; Liu, L; Miao, J; Shen, C; Shi, J; Yu, L; Zhang, Y; Zhao, Z | 1 |
Cauchon, M; Dussault, C; Huard, G; Lanthier, L; Plourde, MÉ | 2 |
Klingenberg, R; Nitschmann, S | 1 |
Lavalle-Cobo, A; Lobo, M; Masson, G; Masson, W; Molinero, G | 1 |
Abbasi, J | 1 |
Holzgreve, H | 1 |
Bach, RG | 1 |
Caspi, D; Elkayam, O; Furer, V | 1 |
Metzler, B; Reindl, M; Reinstadler, SJ | 1 |
Chiarito, M; Condorelli, G; Stefanini, GG | 1 |
Guertin, MC; L'Allier, PL; Tardif, JC | 1 |
Berry, C; Blondeau, L; Bouabdallaoui, N; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Khairy, P; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lelorier, J; Lopez-Sendon, J; Maggioni, AP; Mitchell, D; Orfanos, A; Ostadal, P; Pinto, FJ; Provencher, M; Roubille, F; Samuel, M; Tardif, JC; Waters, DD | 1 |
Akodad, M; Fauconnier, J; Roubille, F; Sicard, P | 1 |
Alam, M; Jneid, H; Koneru, S; Mahtta, D; Silva, GV; Sudhakar, D; Virani, SS | 1 |
Berry, C; Bertrand, OF; Blondeau, L; Bouabdallaoui, N; Diaz, R; Dubé, MP; Gamra, H; Grégoire, JC; Guertin, MC; Ibrahim, R; Kiwan, GS; Koenig, W; Kouz, S; L'Allier, PL; Lim, P; Lopez-Sendon, J; Maggioni, AP; Morel, O; Orfanos, A; Pinto, FJ; Roubille, F; Samuel, M; Tardif, JC; Waters, DD | 1 |
Kraler, S; Lüscher, TF; Wenzl, FA | 1 |
Aimo, A; Barison, A; Bayes-Genis, A; Cediel, G; Emdin, M; Pascual-Figal, DA; Saccaro, LF; Vicente, ÁH | 1 |
Cornel, JH; Hoogeveen, RM; Stroes, ESG | 1 |
Lüscher, TF | 1 |
Aimo, A; Bayes-Genis, A; Emdin, M; Georgiopoulos, G; Pascual Figal, DA | 1 |
Huang, HK; Shih, MC; Tien, YY; Tu, YK | 1 |
Barraclough, J; Cochran, BJ; Kavurma, M; Khandkar, C; Kurup, R; Machet, J; Martinez, G; Misra, A; Pandzic, E; Patel, S; Rye, KA; Tucker, B; Vaidya, K | 1 |
Hiromasa, T; Inaki, A; Kinuya, S; Mori, H; Ogawa, K; Shiba, K; Taki, J; Wakabayashi, H | 1 |
Benchea, L; Covic, A; Kanbay, M; Siriopol, D; Tapoi, L | 1 |
Deftereos, SG; Giannopoulos, GV; Vrachatis, DA | 1 |
Blondeau, L; Bouabdallaoui, N; Tardif, JC | 1 |
Abdel-Latif, A; Abo-Aly, M; Shindo, K; Shokri, E; Wudexi, I | 1 |
Bouabdallaoui, N; Tardif, JC | 2 |
Angoulvant, D; Biere, L; Bochaton, T; Bouleti, C; Boutitie, F; Bresson, D; Croisille, P; De Bourguignon, C; Dhelens, C; Dubreuil, O; Dufay, N; El Jonhy, N; Elbaz, M; Ivanes, F; Maucort-Boulch, D; Mewton, N; Ovize, M; Prieur, C; Prunier, F; Rioufol, G; Roubille, F; Sideris, G | 1 |
Fu, C; Wang, B | 1 |
Budgeon, C; Cornel, JH; Eikelboom, JW; Fiolet, ATL; Jolly, SS; Keech, AC; Kelly, P; Layland, J; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; Tong, DC | 1 |
Andreis, A; Avondo, S; Casula, M; De Ferrari, GM; Imazio, M; Paneva, E; Piroli, F | 1 |
Katira, A; Katira, R | 1 |
Mukherjee, D; Paul, TK | 1 |
Huang, X; Rao, L; Xiong, H; Zhao, J | 1 |
Hao, Y; Jiang, B; Wen, W; Zhang, Z | 1 |
Ebell, MH | 1 |
Cole, J; Freilich, M; Htun, N; Layland, J; Lew, R; Quinn, S | 1 |
Hota, D; Maiti, R; Sethuramalingam, S; Srinivasan, A | 1 |
Bajraktari, G; Banach, M; Bytyçi, I; Henein, MY; Penson, PE | 1 |
Akodad, M; Alos, B; Angoulvant, D; Bidaux, G; Biere, L; Bochaton, T; Bonnefoy-Cudraz, E; Bouleti, C; Boutitie, F; Bresson, D; Croisille, P; Daw, R; De Bourguignon, C; Derimay, F; Dhelens, C; Dubreuil, O; El Jonhy, N; Finet, G; Haider, L; Hayek, A; Ivanes, F; Maucort-Boulch, D; Mewton, N; Prieur, C; Prunier, F; Rioufol, G; Roubille, F | 1 |
Alcock, R; Barlis, P; Butters, J; Dautov, R; Di Giovanni, G; Montarello, NJ; Nerlekar, N; Nicholls, SJ; Nidorf, SM; Ottaway, JL; Patel, S; Psaltis, PJ; Rajendran, S; Salagaras, T; Singh, K; Sinhal, A; Thompson, PL; Wong, DTL | 1 |
Li, C; Li, Q; Li, Z; Lu, C; Peng, Y; Song, L; Wang, L; Wang, Y; Xia, D; Yu, A | 1 |
Marquis-Gravel, G; Tardif, JC | 1 |
Bax, WA; Budgeon, CA; Cornel, JH; den Hartog, F; Duyvendak, M; Eikelboom, JW; El Messaoudi, S; Fiolet, ATL; Mosterd, A; Nidorf, SM; Opstal, TSJ; Thompson, PL; Tijssen, JGP; van Beek, EA; van Broekhoven, A; van Eck, JWM | 1 |
Aguilhon, S; Akodad, M; Blandel, F; Bourret, A; de Santa Barbara, P; Fauconnier, J; Huet, F; Hugon, G; Lacampagne, A; LeGall, M; Roubille, F; Sicard, P | 1 |
Fujisue, K; Ishii, M; Izumiya, Y; Kaikita, K; Kurokawa, H; Matsubara, J; Sugamura, K; Sugiyama, S | 1 |
Bakhta, O; Blanchard, S; Guihot, AL; Jeannin, P; Mirebeau-Prunier, D; Prunier, F; Tamareille, S | 1 |
Chhabra, L; Kowlgi, NG; Spodick, DH | 1 |
Cornel, JH; Fiolet, ATL; Mosterd, A; Nidorf, SM | 1 |
Chatzidou, S; Iliopoulos, DC; Kaminiotis, VV; Kontogiannis, C; Moris, D; Paschou, SA; Siasos, G; Spartalis, E; Spartalis, M; Tsilimigras, DI; Tzatzaki, E; Voudris, V | 1 |
Bowman, M; Hennessy, T; Hillis, GS; Kurup, R; Patel, S; Schultz, C; Soh, L | 1 |
Deodhar, A | 1 |
Abenhaim, L; Alpérovitch, A; Aubrun, E; Danchin, N; Grimaldi-Bensouda, L; Richette, P; Rossignol, M | 1 |
Abad, E; Alburquerque-Béjar, JJ; Fernández-Sanz, C; García-Dorado, D; Inserte, J; Rodríguez-Sinovas, A; Ruiz-Meana, M; Sánchez, JA | 1 |
Alexopoulos, D; Alexopoulos, N; Angelidis, C; Cleman, MW; Deftereos, S; Filippatos, G; Giannopoulos, G; Goudevenos, J; Lekakis, J; Manolis, AS; Papoutsidakis, N; Pyrgakis, V; Sianos, G; Tousoulis, D | 1 |
Arpagaus, A; Briel, M; Ewald, H; Glinz, D; Gloy, VL; Hemkens, LG; Nidorf, M; Nordmann, AJ; Olu, KK | 2 |
Ben-Shoshan, J; Entin-Meer, M; Hertzberg-Bigelman, E; Keren, G; Levy, R; Margolis, G | 1 |
Briel, M; Ewald, H; Hemkens, LG | 1 |
Amoura, Z; Cacoub, P; Geri, G; Isnard, R; Piette, JC; Resche-Rigon, M; Saadoun, D; Thi Huong, DL; Wechsler, B | 1 |
Crittenden, DB; Cronstein, BN; Greenberg, JD; Keenan, RT; Lehmann, RA; Pillinger, MH; Schneck, L; Sedlis, SP; Shah, B | 1 |
Bansal, A; Gupta, I; Jones, J; Mankal, P; Ranade, A; Sandhu, G; Tagani, A | 1 |
HILLECKE, NA | 1 |
Ichikawa, Y; Ikeda, Y; Kobayashi, H; Miki, T; Miura, T; Nakamura, Y; Nakano, A; Shimamoto, K; Yano, T | 1 |
Hillis, LD; Lange, RA | 1 |
Bidwell, S; Davison, C; Phibbs, R; Than, M; Walker, M | 1 |
Cason, BA; Hickey, RF; Ismaeil, MS; Tkachenko, I | 1 |
Sharma, A; Singh, M | 1 |
Chaldakov, GN | 1 |
Jakobsen, TJ; Madsen, SM | 1 |
Smith, CR | 1 |
35 review(s) available for colchicine and Cardiovascular Stroke
Article | Year |
---|---|
Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis.
Topics: Colchicine; Coronary Artery Disease; Drug Interactions; Humans; Myocardial Infarction | 2021 |
Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Stroke | 2022 |
Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.
Topics: Anti-Inflammatory Agents; Cardiovascular Agents; Colchicine; Coronary Artery Disease; COVID-19 Drug Treatment; Humans; Myocardial Infarction | 2022 |
Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Ischemic Stroke; Myocardial Infarction; Randomized Controlled Trials as Topic | 2022 |
Effect of Treatment with Colchicine after Acute Coronary Syndrome on Major Cardiovascular Events: A Systematic Review and Meta-Analysis of Clinical Trials.
Topics: Acute Coronary Syndrome; C-Reactive Protein; Colchicine; Humans; Myocardial Infarction; Stroke | 2022 |
Colchicine linked with risk reduction for myocardial infarction in gout patients: systematic review and meta-analysis.
Topics: Colchicine; Gout; Gout Suppressants; Humans; Myocardial Infarction; Risk Reduction Behavior | 2022 |
Evaluating the Utility of Colchicine in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.
Topics: Acute Coronary Syndrome; Cause of Death; Colchicine; Humans; Myocardial Infarction; Stroke | 2022 |
Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2022 |
Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Percutaneous Coronary Intervention | 2023 |
Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
Topics: Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Colchicine; Heart Failure; Humans; Interleukin-1; Interleukin-6; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke | 2023 |
Low-Dose Colchicine for Secondary Prevention of Coronary Artery Disease: JACC Review Topic of the Week.
Topics: Adult; Atherosclerosis; Cholesterol, LDL; Colchicine; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Myocardial Infarction; Secondary Prevention | 2023 |
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions.
Topics: American Heart Association; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atherosclerosis; Colchicine; Eicosapentaenoic Acid; Humans; Interleukin-6; Mutation; Myocardial Infarction; PCSK9 Inhibitors; Receptors, Interleukin-6; Risk Factors; United States | 2020 |
Role of Colchicine in Stroke Prevention: An Updated Meta-Analysis.
Topics: Anti-Inflammatory Agents; Colchicine; Humans; Incidence; Myocardial Infarction; Protective Factors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Time Factors; Treatment Outcome | 2020 |
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction | 2020 |
Colchicine and myocardial infarction: A review.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Humans; Inflammation; Inflammation Mediators; Myocardial Infarction; Myocarditis; Myocardium; Signal Transduction; Treatment Outcome | 2020 |
Targeting Inflammation After Myocardial Infarction.
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction | 2020 |
Colchicine for the treatment of coronary artery disease.
Topics: Acute Coronary Syndrome; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2021 |
Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
Topics: Acute Coronary Syndrome; Angina Pectoris; Colchicine; Coronary Artery Disease; Dose-Response Relationship, Drug; Gout Suppressants; Humans; Myocardial Infarction; Proportional Hazards Models | 2021 |
Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
Topics: Colchicine; Coronary Artery Disease; Drug Repositioning; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Treatment Outcome | 2021 |
Colchicine Use in Acute Coronary Syndromes: An Update.
Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Cardiovascular Agents; Cardiovascular System; Colchicine; Humans; Myocardial Infarction; Signal Transduction; Treatment Outcome | 2021 |
Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Colchicine; Comparative Effectiveness Research; Coronary Circulation; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Network Meta-Analysis; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2021 |
Colchicine administration for percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Topics: Anti-Inflammatory Agents; Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2021 |
Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients.
Topics: Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention; Stroke | 2022 |
Colchicine in coronary artery disease.
Topics: Acute Coronary Syndrome; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2022 |
Colchicine Reduces MI and Revascularization in Patients with Established Coronary Artery Disease.
Topics: Colchicine; Coronary Artery Disease; Global Health; Humans; Incidence; Myocardial Infarction; Percutaneous Coronary Intervention; Risk Factors; Treatment Outcome; Tubulin Modulators | 2021 |
Effect of Colchicine in Reducing Inflammatory Biomarkers and Cardiovascular Risk in Coronary Artery Disease: A Meta-analysis of Clinical Trials.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Clinical Trials as Topic; Colchicine; Coronary Artery Disease; Heart Disease Risk Factors; Humans; Inflammation; Myocardial Infarction; Risk Factors | 2023 |
Colchicine in the Management of Acute and Chronic Coronary Artery Disease.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2021 |
Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Topics: C-Reactive Protein; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2022 |
Colchicine in Stable Coronary Artery Disease.
Topics: Anti-Inflammatory Agents; Colchicine; Coronary Artery Disease; Gout; Humans; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic; Randomized Controlled Trials as Topic; Secondary Prevention | 2019 |
The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
Topics: Acute Coronary Syndrome; Animals; Anti-Inflammatory Agents; Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Inflammation; Myocardial Infarction; Plaque, Atherosclerotic | 2018 |
Colchicine for prevention of cardiovascular events.
Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Cause of Death; Colchicine; Heart Failure; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk; Stroke | 2016 |
Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Myocardial Infarction; Treatment Outcome | 2016 |
Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature.
Topics: Adult; Anticoagulants; Behcet Syndrome; Cohort Studies; Colchicine; Coronary Thrombosis; Endocarditis; Endomyocardial Fibrosis; Female; Heart Aneurysm; Humans; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardium; Pericarditis; Sex Factors; Treatment Outcome | 2012 |
Clinical practice. Acute pericarditis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chest Pain; Colchicine; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Female; Glucocorticoids; Hospitalization; Humans; Myocardial Infarction; Pericarditis; Pulmonary Embolism; Recurrence | 2004 |
16 trial(s) available for colchicine and Cardiovascular Stroke
Article | Year |
---|---|
Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol.
Topics: Animals; Colchicine; Humans; Mice; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; ST Elevation Myocardial Infarction; Sympathectomy | 2021 |
Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
Topics: Biomarkers; C-Reactive Protein; Colchicine; Humans; Inflammation; Myocardial Infarction | 2022 |
Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI).
Topics: Arrhythmias, Cardiac; C-Reactive Protein; Colchicine; Humans; Myocardial Infarction; P-Selectin; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Treatment Outcome; Troponin | 2022 |
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
Topics: Aged; Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction | 2023 |
The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial.
Topics: Biomarkers; Colchicine; Creatine Kinase, MB Form; Humans; Interleukin-6; Myocardial Infarction; Troponin I; Troponin T | 2023 |
Effect of Colchicine in reducing MMP-9, NOX2, and TGF- β1 after myocardial infarction.
Topics: Aged; Colchicine; Humans; Matrix Metalloproteinase 9; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Transforming Growth Factor beta1; Ventricular Remodeling | 2023 |
Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm paral
Topics: Colchicine; Glucose; Heart Failure; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Sodium; Sodium-Glucose Transporter 2 Inhibitors; ST Elevation Myocardial Infarction; Stroke Volume; Ventricular Function, Left | 2023 |
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Australia; Cardiovascular Diseases; Clinical Trial Protocols as Topic; Colchicine; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug Repositioning; Female; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Percutaneous Coronary Intervention; Secondary Prevention; Stroke; Tubulin Modulators | 2019 |
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
Topics: Aged; Angina Pectoris; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Colchicine; Double-Blind Method; Female; Humans; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Proportional Hazards Models; Recurrence; Stroke | 2019 |
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
Topics: Canada; Colchicine; Cost-Benefit Analysis; Humans; Myocardial Infarction; Quality-Adjusted Life Years | 2021 |
Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
Topics: Angina Pectoris; Colchicine; Humans; Myocardial Infarction; Stroke; Time-to-Treatment; Treatment Outcome | 2020 |
Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
Topics: Adult; Clinical Trials, Phase II as Topic; Colchicine; Humans; Magnetic Resonance Imaging; Multicenter Studies as Topic; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2021 |
Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
Topics: Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Pilot Projects; Treatment Outcome; Troponin I | 2021 |
Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
Topics: Acute Coronary Syndrome; Colchicine; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Myocardial Infarction; Phenotype; Plaque, Atherosclerotic; Tomography, Optical Coherence | 2022 |
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Risk Assessment; Secondary Prevention; Stroke; Time-to-Treatment | 2021 |
Anti-Inflammatory Treatment With Colchicine in Acute Myocardial Infarction: A Pilot Study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Biomarkers; C-Reactive Protein; Colchicine; Creatine Kinase, MB Form; Double-Blind Method; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardium; Pilot Projects; Prospective Studies | 2015 |
52 other study(ies) available for colchicine and Cardiovascular Stroke
Article | Year |
---|---|
Colchicine as potential inhibitor targeting MMP-9, NOX2 and TGF-β1 in myocardial infarction: a combination of docking and molecular dynamic simulation study.
Topics: Colchicine; Humans; Matrix Metalloproteinase 9; Molecular Docking Simulation; Molecular Dynamics Simulation; Myocardial Infarction; Transforming Growth Factor beta1; Ventricular Remodeling | 2023 |
Is Colchicine Involved in Managing Stroke?
Topics: Colchicine; Humans; Myocardial Infarction; Stroke | 2023 |
Recurrent pericarditis.
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction; Pericarditis; Recurrence | 2023 |
Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink.
Topics: Adult; Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Colchicine; Diarrhea; Gout; Gout Suppressants; Humans; Myocardial Infarction; Propensity Score; Retrospective Studies; United Kingdom; Uric Acid | 2023 |
Localized delivery of anti-inflammatory agents using extracellular matrix-nanostructured lipid carriers hydrogel promotes cardiac repair post-myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Colchicine; Drug Carriers; Hydrogels; Lipids; Mice; Myocardial Infarction; Nanostructures; Particle Size | 2023 |
Inflammation as a Treatment Target after Acute Myocardial Infarction.
Topics: Colchicine; Humans; Inflammation; Myocardial Infarction | 2019 |
Anti-inflammatory therapy for secondary prevention after MI.
Topics: Anti-Inflammatory Agents; Colchicine; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Secondary Prevention | 2020 |
85-Year-Old Man With Chest Pain.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Aspirin; Chest Pain; Colchicine; Diagnosis, Differential; Electrocardiography; Humans; Magnetic Resonance Imaging, Cine; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Pericarditis; Platelet Aggregation Inhibitors; Postoperative Complications; Proton Pump Inhibitors; Treatment Outcome; Troponin | 2020 |
An injectable thermosensitive hydrogel loaded with an ancient natural drug colchicine for myocardial repair after infarction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Cell Proliferation; Colchicine; Hydrogels; Injections, Intralesional; Injections, Subcutaneous; Male; Materials Testing; Mice; Mice, Inbred C57BL; Molecular Structure; Myocardial Infarction; Particle Size; Polyesters; Polyethylene Glycols; Surface Properties; Temperature | 2020 |
[In patients with recent myocardial infarction, is colchicine effective in preventing cardiovascular events with a safety profile equivalent to placebo?]
Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Colchicine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
[Colchicine treatment after myocardial infarction : Colchicine Cardiovascular Outcomes Trial (COLCOT)].
Topics: Anti-Inflammatory Agents; Cardiovascular Diseases; Cardiovascular System; Colchicine; Gout Suppressants; Humans; Myocardial Infarction; Tubulin Modulators | 2020 |
Cardiovascular Corner-Stable Coronary Artery Disease, An LDL "Vaccine," and Anti-inflammatories.
Topics: Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents; Anticholesteremic Agents; Cholesterol, LDL; Colchicine; Combined Modality Therapy; Coronary Artery Disease; Humans; Hypercholesterolemia; Inflammation; Myocardial Infarction; RNA, Small Interfering | 2020 |
Low-dose colchicine after MI reduced a composite ischemic cardiovascular outcome vs placebo.
Topics: Colchicine; Humans; Myocardial Infarction | 2020 |
Low-Dose Colchicine after Myocardial Infarction.
Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction | 2020 |
Low-Dose Colchicine after Myocardial Infarction.
Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction | 2020 |
Low-Dose Colchicine after Myocardial Infarction.
Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction | 2020 |
Low-Dose Colchicine after Myocardial Infarction. Reply.
Topics: C-Reactive Protein; Colchicine; Humans; Myocardial Infarction | 2020 |
Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial.
Topics: Cardiovascular Diseases; Colchicine; Heart Disease Risk Factors; Humans; Myocardial Infarction; Risk Factors | 2020 |
[In patients with stable chronic coronary disease, how effective is colchicine in preventing cardiovascular events and what are the adverse reactions when compared to placebo?]
Topics: Chronic Disease; Colchicine; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction | 2020 |
[Anti-inflammatory therapy in cardiovascular disease; from hypothesis to future guideline?]
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Colchicine; Humans; Inflammation; Methotrexate; Myocardial Infarction; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Translational Research, Biomedical | 2020 |
The sooner, the better: anti-inflammation in acute myocardial infarction.
Topics: Anti-Inflammatory Agents; Cardiovascular System; Colchicine; Humans; Myocardial Infarction; Time-to-Treatment | 2020 |
Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
Topics: Acute Coronary Syndrome; Angina, Stable; Anti-Inflammatory Agents; Colchicine; Extracellular Traps; Female; Humans; In Vitro Techniques; Inflammation; Male; Middle Aged; Myocardial Infarction; Neutrophil Activation; Neutrophils; Percutaneous Coronary Intervention; Treatment Outcome | 2021 |
Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by
Topics: Animals; Carbon Radioisotopes; Colchicine; Heart Ventricles; Humans; Male; Methionine; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Rats; Rats, Wistar; Risk Assessment; Stroke Volume; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Colchicine administered early in acute myocardial infarction: ready, set … go?
Topics: Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention | 2021 |
Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease.
Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction; Secondary Prevention | 2021 |
Initiation of low-dose colchicine early after myocardial infarction.
Topics: C-Reactive Protein; Cognition; Colchicine; Humans; Myocardial Infarction | 2021 |
Is Colchicine Beneficial for the Prevention of Cardiovascular Events After Myocardial Infarction?
Topics: Acute Coronary Syndrome; Colchicine; Humans; Myocardial Infarction; Percutaneous Coronary Intervention | 2021 |
Efficacy and safety of colchicine in the treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents; Clinical Protocols; Colchicine; Humans; Meta-Analysis as Topic; Models, Statistical; Myocardial Infarction; Systematic Review as Topic; Treatment Outcome | 2021 |
Orbitrap-MS-based untargeted metabolomics study on the therapeutic effect of colchicine on myocardial infarction.
Topics: Animals; Colchicine; Disease Models, Animal; Heart; Male; Metabolome; Metabolomics; Myocardial Infarction; Myocardium; Rats | 2021 |
Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction.
Topics: Acute Disease; Adult; Aged; Colchicine; Contrast Media; Female; Heart; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Referral and Consultation; ST Elevation Myocardial Infarction; Ventricular Remodeling | 2021 |
Colchicine-Containing Nanoparticles Attenuates Acute Myocardial Infarction Injury by Inhibiting Inflammation.
Topics: Animals; Anti-Inflammatory Agents; Calcium Carbonate; Colchicine; Cytokines; Disease Models, Animal; Inflammation; Myocardial Infarction; Nanoparticles; Rats | 2022 |
Low-Dose Colchicine for the Management of Coronary Artery Disease.
Topics: Atherosclerosis; Colchicine; Coronary Artery Disease; Humans; Myocardial Infarction | 2021 |
Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model.
Topics: Animals; Colchicine; Disease Models, Animal; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Treatment Outcome; Tubulin Modulators | 2017 |
Colchicine Improves Survival, Left Ventricular Remodeling, and Chronic Cardiac Function After Acute Myocardial Infarction.
Topics: Animals; Colchicine; Disease Models, Animal; Male; Mice; Myocardial Infarction; Recovery of Function; Ventricular Remodeling | 2017 |
Cardioprotective Role of Colchicine Against Inflammatory Injury in a Rat Model of Acute Myocardial Infarction.
Topics: Animals; Anti-Inflammatory Agents; Caspase 1; Colchicine; Disease Models, Animal; Drug Therapy, Combination; Inflammasomes; Interleukin-10; Interleukin-18; Interleukin-1beta; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Wistar; Time Factors; Transforming Growth Factor beta1 | 2018 |
Colchicine In Epistenocardiac Pericarditis.
Topics: Aged; Colchicine; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Pericarditis; Platelet Aggregation Inhibitors | 2016 |
The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction.
Topics: Biomarkers; C-Reactive Protein; Colchicine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
Update in rheumatology: evidence published in 2012.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Antiviral Agents; Arthritis; Arthritis, Gouty; Arthritis, Rheumatoid; Autoimmune Diseases; Bacterial Infections; Calcitonin; Colchicine; Cryoglobulinemia; Death, Sudden, Cardiac; Drug Resistance, Viral; Enzyme Inhibitors; Female; Gout; Gout Suppressants; Hand Joints; Hepatitis C, Chronic; Humans; Hyperuricemia; Immunologic Factors; Janus Kinase 3; Male; Myocardial Infarction; Neoplasms; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Practice Guidelines as Topic; Protein Precursors; Pyrimidines; Pyrroles; Registries; Tumor Necrosis Factor-alpha | 2013 |
Impact of allopurinol on risk of myocardial infarction.
Topics: Aged; Allopurinol; Case-Control Studies; Colchicine; Female; Gout; Gout Suppressants; Humans; Hypertension; Logistic Models; Male; Middle Aged; Myocardial Infarction; Protective Factors | 2015 |
Microtubule stabilization with paclitaxel does not protect against infarction in isolated rat hearts.
Topics: Animals; Calcium Signaling; Colchicine; Cytoprotection; Dose-Response Relationship, Drug; Heart Rate; In Vitro Techniques; Male; Mechanotransduction, Cellular; Microtubules; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Paclitaxel; Rats, Sprague-Dawley; Stress, Mechanical; Tubulin Modulators; Ventricular Function, Left; Ventricular Pressure | 2015 |
Differential Effects of Colchicine on Cardiac Cell Viability in an in vitro Model Simulating Myocardial Infarction.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Colchicine; Mice; Myoblasts, Cardiac; Myocardial Infarction; Myocytes, Cardiac; Rats; Tubulin Modulators; Tumor Necrosis Factor-alpha | 2016 |
Colchicine and Prevention of Cardiovascular Events.
Topics: Colchicine; Humans; Myocardial Infarction | 2016 |
Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.
Topics: Aged; Aged, 80 and over; Allopurinol; C-Reactive Protein; Colchicine; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Myocardial Infarction; New York; Prevalence; Retrospective Studies; Treatment Outcome; Uric Acid | 2012 |
Extremely high ferritin level after an acute myocardial infarction in an end stage renal disease patient.
Topics: Anemia, Hemolytic, Autoimmune; Asymptomatic Diseases; Biomarkers; Colchicine; Female; Ferritins; Humans; Hypotension; Kidney Failure, Chronic; Middle Aged; Myocardial Infarction; Pericardial Effusion; Pericardiocentesis; Renal Dialysis; Time Factors; Treatment Outcome; Up-Regulation | 2014 |
ACUTE ANAPHYLACTOID REACTION TO PROBENECID.
Topics: Anaphylaxis; Colchicine; Diagnosis, Differential; Drug Therapy; Gout; Myocardial Infarction; Probenecid; Sulfinpyrazone; Toxicology | 1965 |
Role of microtubules in ischemic preconditioning against myocardial infarction.
Topics: Animals; Biological Transport; Colchicine; Enzyme Activation; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Microtubules; Myocardial Infarction; Myocardium; Nocodazole; p38 Mitogen-Activated Protein Kinases; Perfusion; Protein Kinase C; Rabbits | 2004 |
Evidence-based emergency medicine at the 'coal face'.
Topics: Acyclovir; Adult; Chest Pain; Colchicine; Diagnosis, Differential; Emergency Medicine; Evidence-Based Medicine; Female; Ginkgo biloba; Gout Suppressants; Herpes Zoster; Humans; Male; Migraine Disorders; Myocardial Infarction; Pericarditis; Phytotherapy; Plant Preparations; Troponin | 2005 |
Colchicine inhibits isoflurane-induced preconditioning.
Topics: Anesthetics, Inhalation; Animals; Colchicine; Hemodynamics; Ischemic Preconditioning, Myocardial; Isoflurane; Myocardial Infarction; Rabbits; Ventricular Fibrillation | 1999 |
Possible mechanism of cardioprotective effect of ischaemic preconditioning in isolated rat heart.
Topics: Animals; Colchicine; Creatine Kinase; Female; In Vitro Techniques; Ischemic Preconditioning, Myocardial; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Prazosin; Rats; Rats, Wistar | 2000 |
Proposal for clinical trials using anti-inflammatory drugs in the therapy of angina pectoris, myocardial infarction and coronary restenosis after angioplasty and bypass grafting.
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Clinical Trials as Topic; Colchicine; Griseofulvin; Humans; Myocardial Infarction; Recurrence; Sulfasalazine | 1992 |
[Colchicine treatment of recurrent steroid-dependent pericarditis in a patient with post-myocardial-infarction syndrome (Dressler's syndrome)].
Topics: Colchicine; Female; Humans; Middle Aged; Myocardial Infarction; Pericarditis; Prednisolone; Recurrence; Syndrome | 1992 |
Possible cardioprotective effects of allopurinol.
Topics: Acute Disease; Aged; Allopurinol; Cohort Studies; Colchicine; Drug Combinations; Female; Gout; Health Maintenance Organizations; Hospital Information Systems; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Probenecid; Time Factors; Washington | 1988 |